Safety of topical tacrolimus and corticosteroids in young children with atopic dermatitis: a 5-year questionnaire-based follow-up study
We previously conducted a randomized double-blinded clinical cohort study on topical tacrolimus safety issues in 1–3-year-old children with atopic dermatitis. Five years on, the participants were contacted via a postal questionnaire to obtain long-term data. There were no significant differences reg...
Saved in:
| Published in | Clinical and experimental dermatology Vol. 49; no. 3; pp. 276 - 280 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
England
14.02.2024
|
| Online Access | Get full text |
Cover
Loading…
| Summary: | We previously conducted a randomized double-blinded clinical cohort study on topical tacrolimus safety issues in 1–3-year-old children with atopic dermatitis. Five years on, the participants were contacted via a postal questionnaire to obtain long-term data. There were no significant differences regarding infections, growth parameters (height, weight, body mass index), quality of life and disease severity between use of topical tacrolimus and topical corticosteroids. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ISSN: | 0307-6938 1365-2230 |
| DOI: | 10.1093/ced/llad379 |